GRID2IP and bladder transitional cell carcinoma: The results show that GRID2IP is found in bladder carcinoma(BLCA), cholangiocarcinoma (CHOL), colon adenocarcinoma(COAD), lung adenocarcinoma(LUAD) was highly expressed and low expressed in KICH, KIRC and HNSC (Fig. 1A).